Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
13.5 GBX | +8.87% | +58.82% | +114.29% |
Dec. 04 | ADRs Close Lower; Aslan Pharmaceuticals Declines 17% | DJ |
Dec. 04 | Argo Blockchain's Bitcoin Production, Mining Revenue Rise in November | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- Analyst opinion has improved significantly over the past four months.
Weaknesses
- Low profitability weakens the company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Sector : Blockchain & Cryptocurrency
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+114.29% | 84 M $ | - | ||
+363.74% | 3 402 M $ | D+ | ||
+342.92% | 3 127 M $ | D+ | ||
+349.51% | 1 720 M $ | C- | ||
+392.88% | 717 M $ | - | ||
+381.25% | 631 M $ | - | ||
-44.34% | 621 M $ | - | - | |
+195.38% | 595 M $ | - | ||
+143.39% | 369 M $ | - | ||
+459.97% | 301 M $ | - |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-
Valuation
P/E ratio
-
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock
- Equities
- Stock Argo Blockchain plc - London Stock Exchange
- Ratings Argo Blockchain plc